drugset / Trial / NCT01097252

Weekly Versus Three-week Chemoradiation in Patients With Advanced Cervical Cancer

NCT01097252 ↗

Phase 3 Completed 104 enrolled Korea Cancer Center Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

Three weekly cisplatin based chemoradiation is to be compared the compliance, toxicity, and response rates with the weekly cisplatin based chemoradiation in the treatment of locoregionally advanced cervical cancers.

Timeline

Start
2002-01
Primary completion
2004-12
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cisplatin Other / unclassified 40 mg/m2 —
Comparator Cisplatin Other / unclassified 75 mg/m2 —

Indications